File Download
 
 
Supplementary

Conference Paper: Predicting future blood demand in Thalassemia patients in Hong Kong Chinese
  • Basic View
  • Metadata View
  • XML View
TitlePredicting future blood demand in Thalassemia patients in Hong Kong Chinese
 
AuthorsLau, HY
He, X
Wu, TK
Lee, CK
 
KeywordsMedical sciences
Allergology and immunology medical sciences
Cardiovascular diseases
 
Issue Date2011
 
PublisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/VOX
 
CitationThe 22nd Regional Congress of the International Society of Blood Transfusion (ISBT), Taipei, Taiwan, 19-23 November 2011. In Vox Sanguinis, 2011, v. 101 suppl. s2, p. 35-36, abstract no. 5A-S19-03 [How to Cite?]
 
AbstractBACKGROUND: Increasing blood demand is well observed in almost all parts of the world with longer longevity and hence more blood transfusion for chronic illnesses, surgical and orthopaedic procedures and cancer treatment. Although incidence of genetic diseases like thalassaemia major should diminish with better antenatal diagnosis, but their survival has been significantly improved with more medical treatment and transfusion support. We are interested at this small number of patients that utilizing about 10% of blood supply in Hong Kong annually. By looking at their annual demand pattern, age and medical status, we derive model to forecast their blood demand from 2010 to 2019. METHODS: Annual transfusion data in 2005–2009 and demographic information of 382 thalassemia patients were obtained from Hong Kong Red Cross Blood Transfusion Service database. A generalized estimating equation (GEE) model was fitted to establish the relation between age, sex, body weight, year of transfusion and splenectomy with blood demand, adjusted for within-patient correlation. Future blood demand for the existing patients was predicted based on the fitted model accounted for expected change in body weights for patients under 20 years according to the US CDC growth curve [1]. We also derived the age and sex-specific incidence of thalassemia from data in 2006–2009 and predict future new cases based on the projected Hong Kong population from Census and Statistics Department [2]. The future blood demand from these cases was predicted based on the fitted GEE model. The combined blood demand from the existing and new patients gives the total predicted blood demand. RESULTS: Three hundred and eighty-two thalassemia patients were retrieved to construct the GEE model and 10 patients were excluded due to intermittent blood consumption in 2005–2009. Female and splenectomy significantly associated with a lower blood demand, while age and weight have an inverted U-shape relation with maximal blood demand at around 24 years old and 66.3 kg respectively. After adjusted for these factors, no significant time trend was found. The total blood demand in 2005 was 12,442 units and has a 2.4% annual increase to 13,668 units in 2009. For these existing patients, blood demand is predicted to increase to 13,931.1 units (prediction interval, PI = 13,191.2–14,670.9) in 2014 then decrease to 13,382.6 units (PI = 12,671.3–14,093.9) in 2019. By including all new patients, blood demand is predicted to increase from 13,668 units in 2009 to 16,423.6 units (confidence interval = 14,959.1–17,888.2) in 2019 at an annual rate of 1.85%. CONCLUSIONS: The results show that the future annual blood demand in thalassemia patients will increase by 20.2% to 16,423.6 units in 2019. Reducing incidence of new thalassemia cases through public education, antenatal care, prenatal diagnosis, minimizing blood use in existing cases with hemopoietic stem cell transplantation or splenectomy may help better management of future blood demand.
 
DescriptionOral Presentation - Parallel Sessions: S19 - Managing thalassaemia
 
ISSN0042-9007
2013 Impact Factor: 3.303
 
DC FieldValue
dc.contributor.authorLau, HY
 
dc.contributor.authorHe, X
 
dc.contributor.authorWu, TK
 
dc.contributor.authorLee, CK
 
dc.date.accessioned2012-03-27T09:06:04Z
 
dc.date.available2012-03-27T09:06:04Z
 
dc.date.issued2011
 
dc.description.abstractBACKGROUND: Increasing blood demand is well observed in almost all parts of the world with longer longevity and hence more blood transfusion for chronic illnesses, surgical and orthopaedic procedures and cancer treatment. Although incidence of genetic diseases like thalassaemia major should diminish with better antenatal diagnosis, but their survival has been significantly improved with more medical treatment and transfusion support. We are interested at this small number of patients that utilizing about 10% of blood supply in Hong Kong annually. By looking at their annual demand pattern, age and medical status, we derive model to forecast their blood demand from 2010 to 2019. METHODS: Annual transfusion data in 2005–2009 and demographic information of 382 thalassemia patients were obtained from Hong Kong Red Cross Blood Transfusion Service database. A generalized estimating equation (GEE) model was fitted to establish the relation between age, sex, body weight, year of transfusion and splenectomy with blood demand, adjusted for within-patient correlation. Future blood demand for the existing patients was predicted based on the fitted model accounted for expected change in body weights for patients under 20 years according to the US CDC growth curve [1]. We also derived the age and sex-specific incidence of thalassemia from data in 2006–2009 and predict future new cases based on the projected Hong Kong population from Census and Statistics Department [2]. The future blood demand from these cases was predicted based on the fitted GEE model. The combined blood demand from the existing and new patients gives the total predicted blood demand. RESULTS: Three hundred and eighty-two thalassemia patients were retrieved to construct the GEE model and 10 patients were excluded due to intermittent blood consumption in 2005–2009. Female and splenectomy significantly associated with a lower blood demand, while age and weight have an inverted U-shape relation with maximal blood demand at around 24 years old and 66.3 kg respectively. After adjusted for these factors, no significant time trend was found. The total blood demand in 2005 was 12,442 units and has a 2.4% annual increase to 13,668 units in 2009. For these existing patients, blood demand is predicted to increase to 13,931.1 units (prediction interval, PI = 13,191.2–14,670.9) in 2014 then decrease to 13,382.6 units (PI = 12,671.3–14,093.9) in 2019. By including all new patients, blood demand is predicted to increase from 13,668 units in 2009 to 16,423.6 units (confidence interval = 14,959.1–17,888.2) in 2019 at an annual rate of 1.85%. CONCLUSIONS: The results show that the future annual blood demand in thalassemia patients will increase by 20.2% to 16,423.6 units in 2019. Reducing incidence of new thalassemia cases through public education, antenatal care, prenatal diagnosis, minimizing blood use in existing cases with hemopoietic stem cell transplantation or splenectomy may help better management of future blood demand.
 
dc.description.naturelink_to_OA_fulltext
 
dc.descriptionOral Presentation - Parallel Sessions: S19 - Managing thalassaemia
 
dc.description.otherThe 22nd Regional Congress of the International Society of Blood Transfusion (ISBT), Taipei, Taiwan, 19-23 November 2011. In Vox Sanguinis, 2011, v. 101 suppl. s2, p. 35-36, abstract no. 5A-S19-03
 
dc.identifier.citationThe 22nd Regional Congress of the International Society of Blood Transfusion (ISBT), Taipei, Taiwan, 19-23 November 2011. In Vox Sanguinis, 2011, v. 101 suppl. s2, p. 35-36, abstract no. 5A-S19-03 [How to Cite?]
 
dc.identifier.epage36
 
dc.identifier.hkuros198849
 
dc.identifier.issn0042-9007
2013 Impact Factor: 3.303
 
dc.identifier.issuesuppl. s2
 
dc.identifier.spage35
 
dc.identifier.urihttp://hdl.handle.net/10722/146010
 
dc.identifier.volume101
 
dc.languageeng
 
dc.publisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/VOX
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofVox Sanguinis
 
dc.rightsThe definitive version is available at www.blackwell-synergy.com
 
dc.subjectMedical sciences
 
dc.subjectAllergology and immunology medical sciences
 
dc.subjectCardiovascular diseases
 
dc.titlePredicting future blood demand in Thalassemia patients in Hong Kong Chinese
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lau, HY</contributor.author>
<contributor.author>He, X</contributor.author>
<contributor.author>Wu, TK</contributor.author>
<contributor.author>Lee, CK</contributor.author>
<date.accessioned>2012-03-27T09:06:04Z</date.accessioned>
<date.available>2012-03-27T09:06:04Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>The 22nd Regional Congress of the International Society of Blood Transfusion (ISBT), Taipei, Taiwan, 19-23 November 2011. In Vox Sanguinis, 2011, v. 101 suppl. s2, p. 35-36, abstract no. 5A-S19-03</identifier.citation>
<identifier.issn>0042-9007</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/146010</identifier.uri>
<description>Oral Presentation - Parallel Sessions: S19 - Managing thalassaemia</description>
<description.abstract>BACKGROUND: Increasing blood demand is well observed in almost all parts of the world with longer longevity and hence more blood transfusion for chronic illnesses, surgical and orthopaedic procedures and cancer treatment. Although incidence of genetic diseases like thalassaemia major should diminish with better antenatal diagnosis, but their survival has been significantly improved with more medical treatment and transfusion support. We are interested at this small number of patients that utilizing about 10% of blood supply in Hong Kong annually. By looking at their annual demand pattern, age and medical status, we derive model to forecast their blood demand from 2010 to 2019. METHODS: Annual transfusion data in 2005&#8211;2009 and demographic information of 382 thalassemia patients were obtained from Hong Kong Red Cross Blood Transfusion Service database. A generalized estimating equation (GEE) model was fitted to establish the relation between age, sex, body weight, year of transfusion and splenectomy with blood demand, adjusted for within-patient correlation. Future blood demand for the existing patients was predicted based on the fitted model accounted for expected change in body weights for patients under 20 years according to the US CDC growth curve [1]. We also derived the age and sex-specific incidence of thalassemia from data in 2006&#8211;2009 and predict future new cases based on the projected Hong Kong population from Census and Statistics Department [2]. The future blood demand from these cases was predicted based on the fitted GEE model. The combined blood demand from the existing and new patients gives the total predicted blood demand. RESULTS: Three hundred and eighty-two thalassemia patients were retrieved to construct the GEE model and 10 patients were excluded due to intermittent blood consumption in 2005&#8211;2009. Female and splenectomy significantly associated with a lower blood demand, while age and weight have an inverted U-shape relation with maximal blood demand at around 24 years old and 66.3 kg respectively. After adjusted for these factors, no significant time trend was found. The total blood demand in 2005 was 12,442 units and has a 2.4% annual increase to 13,668 units in 2009. For these existing patients, blood demand is predicted to increase to 13,931.1 units (prediction interval, PI = 13,191.2&#8211;14,670.9) in 2014 then decrease to 13,382.6 units (PI = 12,671.3&#8211;14,093.9) in 2019. By including all new patients, blood demand is predicted to increase from 13,668 units in 2009 to 16,423.6 units (confidence interval = 14,959.1&#8211;17,888.2) in 2019 at an annual rate of 1.85%. CONCLUSIONS: The results show that the future annual blood demand in thalassemia patients will increase by 20.2% to 16,423.6 units in 2019. Reducing incidence of new thalassemia cases through public education, antenatal care, prenatal diagnosis, minimizing blood use in existing cases with hemopoietic stem cell transplantation or splenectomy may help better management of future blood demand.</description.abstract>
<language>eng</language>
<publisher>Blackwell Publishing Ltd. The Journal&apos;s web site is located at http://www.blackwellpublishing.com/journals/VOX</publisher>
<relation.ispartof>Vox Sanguinis</relation.ispartof>
<rights>The definitive version is available at www.blackwell-synergy.com</rights>
<subject>Medical sciences</subject>
<subject>Allergology and immunology medical sciences</subject>
<subject>Cardiovascular diseases</subject>
<title>Predicting future blood demand in Thalassemia patients in Hong Kong Chinese</title>
<type>Conference_Paper</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.hkuros>198849</identifier.hkuros>
<identifier.volume>101</identifier.volume>
<identifier.issue>suppl. s2</identifier.issue>
<identifier.spage>35</identifier.spage>
<identifier.epage>36</identifier.epage>
<publisher.place>United Kingdom</publisher.place>
<description.other>The 22nd Regional Congress of the International Society of Blood Transfusion (ISBT), Taipei, Taiwan, 19-23 November 2011. In Vox Sanguinis, 2011, v. 101 suppl. s2, p. 35-36, abstract no. 5A-S19-03</description.other>
<bitstream.url>http://hub.hku.hk/bitstream/10722/146010/1/re01.htm</bitstream.url>
</item>